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E-mail: altorres@utmb.eduIntroductionDiarrhoea is one of the global leading causes of death in chil-
dren <5 years of age, especially in low-income countries [1,2],
accounting for 800 000 fatalities per year worldwide. Entero-
pathogenic Escherichia coli (EPEC is a major cause of infantile
diarrhoea in developing countries (Fig. 1). It was ﬁrst described
in 1955 when a number of E. coli strains, epidemiologically
associated with outbreaks in 1940s and 1950s, were described
[3]. A hallmark phenotype of EPEC is the induction of a
distinctive histopathology known as the attaching and effacing
(A/E) lesion, which is characterized by the effacement of the
intestinal microvilli and the intimate attachment of the bacteria
to the host epithelial surface [4]. After entering the gastroin-
testinal tract, EPEC adhere to the mucosa of the small and large
intestines and at least three steps for pathogenesis have been
described [5]. The initial step includes adherence to the hostClinical Microbiology and Infection © 2015 European Society of Ccell. After attachment, a type III secretion system would be used
to inject virulence factors in the host cell. Finally, an intimate
bacterial attachment and pedestal formation is observed. The
initial deﬁnition of EPEC indicated that this pathotype is part of
the diarrhoeagenic E. coli strains that have the ability to produce
the A/E lesion without producing Shiga toxin (stx–) [6,7].
Currently, the EPEC pathotype is subdivided into typical
EPEC (tEPEC) and atypical EPEC (aEPEC) strains. This classiﬁ-
cation is initially based on the presence of EPEC adherence
factor plasmid (pEAF) [8]. The bfp and per are two important
loci encoded on the plasmid, with bfp encoding the type IV
bundle-forming pilus (BFP), which promotes bacterial micro-
colony formation [9]. The per operon encodes a transcriptional
activator called the plasmid-encoded regulator of the Locus for
Enterocyte Effacement (LEE) pathogenicity island [10,11].
Typical EPEC strains are more homogeneous in their virulence
traits than aEPEC. Most of the typical strains produce the
virulence factors encoded by the LEE region and EAF plasmid
[8]. Atypical EPEC might possess enteroaggregative heat-stable
toxin (EAST1) and other potential virulence factors not enco-
ded in the LEE, such as a haemolysin [8]. EPEC belongs to
speciﬁc O:H serotypes and at least 13 O groups are repre-
sentative of these strains: O26, O39, O55, O86, O88, O103,
O111, O114, O119, O125ac, O126, O127, O128ab, O142,Clin Microbiol Infect 2015; 21: 729–734
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FIG. 1. Distribution of recent worldwide epidemiological studies of enteropathogenic Escherichia coli (EPEC). The arrows represent the increase or
decrease of typical EPEC (tEPEC) and atypical EPEC (aEPEC) incidence per geographical region. The blue stars depict those countries with increased
EPEC prevalence reported in recent years. The red triangles represent countries with recent reported aEPEC outbreaks.
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are more closely related to LEE-positive Shiga toxin-producing
E. coli (e.g. STEC O157:H7) in their genetic characteristics and
virulence properties. The tEPEC and aEPEC strains also have
different adherence patterns. While tEPEC strains display the
localized adherence pattern, the atypical strains can produce a
localized-like adherence, a diffuse adherence, or an aggregative
adherence pattern [8]. Typical EPEC are rarely found in animals
and humans are the major reservoir [8]; aEPEC are present in
both healthy and diseased animals and humans [13].
Diarrhoeal cases caused by EPEC varied from subclinical to
fatal infections [14]. The tEPEC strains can cause abundant
secretory diarrhoea with mucus and signiﬁcant losses of water
and electrolyte in the faeces [15]. In addition, EPEC may lead to
severe malabsorption of nutrients, which would progress to
nutritional aggravation and persistence of diarrhoea [16].
Studies in volunteers demonstrated that a large bacterial inoc-
ulum (109 to 1010) during short incubation periods (12 to 24 h)
is able to induce diarrhoea in adults [17]. For aEPEC, the role as
a diarrhoeagenic pathogen in disease is controversial. The
pathogenesis of aEPEC seems to be related to the serotypes of
aEPEC [18]. For example, in the case of aEPEC O128:H2, after
administration to 15 adult volunteers, none of them became illClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect[17]. It has also been shown that a tEPEC O127:H6 strain
without EAF plasmid was less virulent for adult volunteers than
the wild-type strain [19]. However, there are also plenty of
reports showing that aEPEC causes outbreaks linked to diar-
rhoea (Fig. 1). In a Japanese daycare centre, the only diar-
rhoeagenic pathogen isolated from patients was aEPEC
O55:HNM and these clones showed indistinguishable pulsed
ﬁeld gel electrophoresis patterns [20]. Escherichia coli O111:B4
was responsible for a diarrhoeal outbreak including 611 pupils
and 39 adults in Finland [21]. Escherichia coli O39:NM was also
associated with an outbreak involving more than 100 adults in
the USA [22]. An aEPEC EC3605 caused an outbreak in 75
students (ages 12 to 15 years) in Japan [23] and another aEPEC
strain O127a:K63 was isolated from a 2010 food-poisoning
outbreak involving 112 adults in China. This strain displayed
multidrug resistance to quinolones and extended spectrum
cephalosporins [24].
Some aEPEC are strongly associated with acute disease, but
some strains are also associated with persistent diarrhoea
[25–28]. Santona et al. identiﬁed 28 aEPEC strains among 402
E. coli strains isolated from the faeces of children with acute
diarrhoea in Italy [29]. A study carried out in Australia
compared aEPEC-infected patients with patients infected withious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 729–734
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with aEPEC experienced mild, non-dehydrating, non-inﬂam-
matory diarrhoea that was not associated with fever, vomiting
or abdominal pain; however, the duration of diarrhoea was
longer. Strains of aEPEC were also found to be the most
common pathogens among children with persistent diarrhoea
(diarrhoea lasting for more than 14 days) in Australia (43%) and
Norway (22%) [5]. The exact mechanism of how EPEC causes
diarrhoea is not well established. However, it is postulated that
the extensive disruption of the intestinal microvilli may lead to a
decrease in absorptive surfaces, affecting absorptive channels,
thereby contributing to diarrhoea [30]. Other mechanisms that
may participate in the diarrhoeal process include the effect of
type III secretion system effectors on the intestinal cell. The
type III secretion system effectors Tir, Map, EspF and EspG play
a role in water and ion channel transport activity of intestinal
epithelium. Also, EspF, EspG and Map disrupt the tight junctions
and enhance intestinal permeability, which may lead to diar-
rhoea [31].
Some aEPEC isolates have been linked to bloody diarrhoea.
A study in Germany from January 1995 to June 2007 found that
aEPEC strains were isolated from 18 (15.3%) of 118 patients
with bloody diarrhoea and from 141 (1.3%) of 10 550 patients
with non-bloody diarrhoea. Bielaszewska et al. found that these
strains were originally STEC O103 isolates that lost the Shiga
toxin phage [32]. Finally, aEPEC may become the precursor for
stx-positive isolates. Sekse et al. showed that aEPEC O103:H25
can be converted to STEC by an stx bacteriophage infection and
become more virulent [33].Recent epidemiological reports of EPECCurrently, EPEC is estimated to be responsible for 5–10% of
paediatric diarrhoea in developing countries such as Brazil,
Chile, Peru and Iran [5]. For many decades, tEPEC have been
considered to be strongly associated with infantile diarrhoea in
developing countries. In several studies conducted in Latin
America, tEPEC was found to be the main cause of endemic
diarrhoea in children <1 year of age. The frequency of tEPEC
infection drops with increase in age group and adults rarely
experience tEPEC episodes [5]. This may be due to develop-
ment of immunity or the loss of receptors interacting with
some speciﬁc adhesins. Although tEPEC were major agents of
acute diarrhoea in infants until the 1990s, there is a clear
decline in many of these countries [8]. The Global Enteric
Multicenter Study was a population-based case–control study
including seven countries in Africa and Asia with the goal to
identify the aetiology, burden and mortality of acute moderate
to severe diarrhoea in children <5 years of age [34]. At mostClinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyGlobal Enteric Multicenter Study study sites, tEPEC strains
were not among the leading pathogens that cause acute mod-
erate and severe diarrhoea. The reasons for the decline in cases
are not known, but may be linked to improvements in public
health measures such as active interventions, therapy, sanitary
conditions and control of hospital infections [8,12]. However,
tEPEC infection seems to be associated with a 2.8-fold
increased risk of death among infants ages 0–11 months [34].
Atypical EPEC continue to be frequently detected in both
developing countries and industrialized countries [35]. They are
often associated with diarrhoea and in some countries they
outnumber tEPEC infections. Studies from 13 developing
countries showed that aEPEC isolates were responsible for 78%
(131/169) of all EPEC cases in children <5 years old [5].
Wheeler et al. identiﬁed 142 aEPEC strains and only one tEPEC
among 2774 samples isolated from symptomatic children in the
UK [36,37]. In another study, 61 EPEC strains were isolated
from stool samples of symptomatic persons from 2008 to 2011
in Australia [38], where 95.1% (58/61) were aEPEC. In 2009,
aEPEC strain O76 was associated with a nursery outbreak in
Finland [39]. Further, Sakkejha et al. studied 109 EPEC isolates
detected in England from 2010 to 2012, with 93% of the pa-
tients reporting diarrhoeal episodes and 32% bloody diarrhoea.
The study found that aEPEC were more common and were
associated with a wider variety of serogroups than tEPEC [40].
Overall, according to 266 studies published between 1990
and 2002, EPEC are still among the most important pathogens
causing diarrhoea [35]. As such, in 2014 a European, multi-
centre, prospective quarterly point-prevalence study of
community-acquired diarrhoea (EUCODI) showed that EPEC is
highly prevalent during both the ﬁrst (January 2014) and the
second (April 2014) rounds of the survey ([41]). However,
there are important regional and temporal variations. In Asia, a
separate study found that EPEC (no information about whether
the isolates were tEPEC or aEPEC) was responsible for 3.2% of
648 diarrhoea samples in children <5 years old in an Indian
hospital [42].Asymptomatic hosts carrying EPECAlthough there is a signiﬁcant strong association between EPEC
and infant diarrhoea, many studies have found EPEC, especially
aEPEC, in asymptomatic controls [5]. The recent EUCODI
study shows that EPEC was the most frequent pathogen
detected in mixed infections [41]. A study in the Netherlands
collected 5197 samples from 29 child-care centres, with 95.4%
of samples from children who had no gastroenteritis symptoms
at time of sampling and EPEC isolates were most prevalent in
asymptomatic samples (19.9%) [43]. Another survey inand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 729–734
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children with diarrhoea (7.6%) and those from asymptomatic
controls (9.9%) [44]. A study in Mexico found that although
aEPEC is most prevalent among diarrhoeagenic E. coli, most
isolates are from asymptomatic carriers [25]. A recent survey
in Germany demonstrated that EPEC has a similar high preva-
lence (17.4%) in both control and diarrhoeal patients [41].
It has been proposed that at least three reasons exist
explaining the frequency of EPEC in symptomatic and control
patients. The ﬁrst one is host susceptibility. The precise
mechanism leading to the diarrhoea is not fully understood
[45]. Enteropathogens may initiate pathogenesis by binding to
the host surface speciﬁc receptors, including sugar moieties as
well as proteins. The susceptibility to infection may be associ-
ated with presence or lack of receptors [46]. Non-speciﬁc host
barriers may also prevent bacterial pathogenesis. The intact
barriers, such as the intestinal microbiota, mucus layer and
epithelial cell layer, may prevent diarrhoeal episodes [46]. The
immune status of the host prevents clinical illness but does not
prevent intestinal colonization. Experiments carried out with
enterotoxigenic E. coli and Shigella have shown that in endemic
areas, where individuals are repetitively exposed to enter-
opathogens, individuals might carry pathogens without suffering
from diarrhoeal episodes [47].
It is well known that secretory immunoglobulin A (sIgA)
antibodies from intestine and breast milk as well as human
breast milk oligosaccharides can prevent enterocyte coloniza-
tion or mucosal invasion by enteropathogens without killing the
bacteria [48]. Breastfeeding can prevent diarrhoea in infants and
toddlers and protection is due to the presence of sIgA or non-
speciﬁc factors, such as lactoferrin and enterotoxin-binding ol-
igosaccharides. In endemic areas, the colostrum of puerperal
women is rich in sIgA against EPEC [49–51]. A study in Peru
showed that EPEC prevalence increased with age within the ﬁrst
2 years of life [52]. EPEC was found in 3% of diarrhoea samples
in children <6 months old, in 11% of children 6–12 months old,
and in 16% of children 13–24 months old. Small infants may be
protected from symptomatic EPEC infection due to breast-
feeding. In addition, children may acquire natural immunity in
some developing countries where EPEC is highly endemic [5].
Host age also plays a role for carrying bacteria asymptomatically.
Neter et al. showed that almost 100% of children developed
LPS-speciﬁc antibodies against three of the most common O
serogroups by the age of 12 years [3]. Opintan et al. found that
although EPEC is one of the most common pathogens recov-
ered from healthy individuals aged 3 years, it has not been
detected in healthy infants <2 years old [53].
The second reason is linked to bacterial factors. EPEC strains
are heterogeneous serotypes that include different clones or
genetic lineages [8]. Some strains cause diarrhoea moreClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectfrequently than others at the same challenge inoculum. EPEC
strain E2348/69 causes more severe diarrhoea than strain E74/
68 [46]. Several studies have identiﬁed certain virulence genes
signiﬁcantly associated with diarrhoea. Afset et al. used DNA
microarray to analyse aEPEC strains isolated from children with
and without diarrhoea. Genomic DNA was hybridized against
242 different oligonucleotide probes. They found O-island 122
(OI-122), carrying efa1/lifA and several other genes, signiﬁcantly
associated with diarrhoea. In contrast, the phylogenetic marker
gene yhaA was negatively associated with diarrhoea. Children
with diarrhoea were infected with OI-122 efa1/lifA-positive,
yhaA-negative strains, whereas children without diarrhoea had
aEPEC strains that were OI-122 efa1/lifA-negative, yhaA-positive
[54]. Afset et al. further compared the phylogenetic ancestry
and diarrhoea association of aEPEC strains [55]. Fifty-six aEPEC
strains were divided into four phylogenetic groups (B1, A, D,
B2) and they found a borderline signiﬁcant association with
diarrhoea for the phylogenetic groups B1 and D. Wang et al.
also tried to distinguish aEPEC from diarrhoeic patients and
healthy controls. Multiplex real-time PCR was used to examine
the intimin gene typing, phylogenetic grouping and virulence
proﬁle of isolated aEPEC strains. After examining 159 strains
from 679 samples, their results indicated that aEPEC, particu-
larly those from phylogenetic groups B1 or D, virulence group
Ia, or intimin typing β1 and γ1, induce diarrhoea in humans [56].
Contreras et al. also characterized a collection of EPEC strains
obtained from a study in Peru using PCR-restriction fragment
length polymorphism analysis. They found that the κ-intimin
allele had the highest clinical severity score compared with
other alleles [57].
The third possibility is the variability of diagnostic tests.
Barletta et al. hypothesized that presence of symptoms in EPEC
infections is related to the bacterial load [58]. They analysed
stool samples from a passive surveillance diarrhoeal cohort
study, including 1034 Peruvian children. They isolated EPEC
with a similar frequency from children with diarrhoea and
asymptomatic controls. However, a quantitative real-time PCR
assay was applied to determine whether bacterial loads were
related to diarrhoea and it was found that bacterial load was
signiﬁcantly higher in the diarrhoea group than in the control
group among children with EPEC as the sole pathogen and
among children <1 year old. However, it is evident that this
detection method had some limitations due to the complexity
in faecal samples.
Several other factors may also affect the results reported in
different studies. For example, the control samples may be
collected from pre- or post-symptomatic patients. Other issues
include the sample size, which may not be large enough, or the
fact that asymptomatic controls may transmit EPEC to other
patients, which cannot be excluded [43]. Finally, environmentalious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 729–734
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contamination, may also lead to the bacteria load in control
groups [35].
In summary, cumulative data in recent years has indicated
that aEPEC are more prevalent than tEPEC in both developing
and developed countries. However, tEPEC is still considered
bona ﬁde pathogens because of their arsenal of virulence factors
and association with severe, lethal disease. The recent emer-
gence of aEPEC requires further epidemiological studies that
can help to elucidate whether certain serotypes are speciﬁcally
linked to disease in humans. Further, more investigation is
required to identify virulence/ﬁtness factors of aEPEC that
mediate the disease process or the ability to be maintained in
patients and in healthy individuals. Future studies will answer
whether aEPEC is a foe or an innocent bystander in human
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